70 related articles for article (PubMed ID: 18519236)
1. The effect of tyrosine kinase inhibitors, tyrphostins: AG1024 and SU1498, on autocrine growth of prostate cancer cells (DU145).
Kisielewska J; Ligeza J; Klein A
Folia Histochem Cytobiol; 2008; 46(2):185-91. PubMed ID: 18519236
[TBL] [Abstract][Full Text] [Related]
2. Growth factor/growth factor receptor loops in autocrine growth regulation of human prostate cancer DU145 cells.
Ligęza J; Ligęza J; Klein A
Acta Biochim Pol; 2011; 58(3):391-6. PubMed ID: 21887406
[TBL] [Abstract][Full Text] [Related]
3. The effect of tyrphostins AG494 and AG1478 on the autocrine growth regulation of A549 and DU145 cells.
Bojko A; Reichert K; Adamczyk A; Ligęza J; Ligęza J; Klein A
Folia Histochem Cytobiol; 2012 Jul; 50(2):186-95. PubMed ID: 22763976
[TBL] [Abstract][Full Text] [Related]
4. Modulatory Effects of Curcumin and Tyrphostins (AG494 and AG1478) on Growth Regulation and Viability of LN229 Human Brain Cancer Cells.
Bojko A; Cierniak A; Adamczyk A; Ligeza J
Nutr Cancer; 2015; 67(7):1170-82. PubMed ID: 26364505
[TBL] [Abstract][Full Text] [Related]
5. Silibinin impairs constitutively active TGFalpha-EGFR autocrine loop in advanced human prostate carcinoma cells.
Tyagi A; Sharma Y; Agarwal C; Agarwal R
Pharm Res; 2008 Sep; 25(9):2143-50. PubMed ID: 18253818
[TBL] [Abstract][Full Text] [Related]
6. Genistein and AG1024 synergistically increase the radiosensitivity of prostate cancer cells.
Tang Q; Ma J; Sun J; Yang L; Yang F; Zhang W; Li R; Wang L; Wang Y; Wang H
Oncol Rep; 2018 Aug; 40(2):579-588. PubMed ID: 29901146
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase inhibitors as antiproliferative agents against an estrogen-dependent breast cancer cell line in vitro.
Twaddle GM; Turbov J; Liu N; Murthy S
J Surg Oncol; 1999 Feb; 70(2):83-90. PubMed ID: 10084649
[TBL] [Abstract][Full Text] [Related]
8. Sodium orthovanadate affects growth of some human epithelial cancer cells (A549, HTB44, DU145).
Klein A; Holko P; Ligeza J; Kordowiak AM
Folia Biol (Krakow); 2008; 56(3-4):115-21. PubMed ID: 19055035
[TBL] [Abstract][Full Text] [Related]
9. The effect of vanadyl sulphate (VOSO4) on autocrine growth of human epithelial cancer cell lines.
Holko P; Ligeza J; Kisielewska J; Kordowiak AM; Klein A
Pol J Pathol; 2008; 59(1):3-8. PubMed ID: 18655364
[TBL] [Abstract][Full Text] [Related]
10. Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells.
Takaoka S; Iwase M; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
Int J Oncol; 2007 Jun; 30(6):1469-76. PubMed ID: 17487368
[TBL] [Abstract][Full Text] [Related]
11. A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells.
Patra N; De U; Kim TH; Lee YJ; Ahn MY; Kim ND; Yoon JH; Choi WS; Moon HR; Lee BM; Kim HS
Biomed Pharmacother; 2013 Jun; 67(5):407-15. PubMed ID: 23583193
[TBL] [Abstract][Full Text] [Related]
12. TGF-alpha-driven tumor growth is inhibited by an EGF receptor tyrosine kinase inhibitor.
El-Obeid A; Hesselager G; Westermark B; Nistér M
Biochem Biophys Res Commun; 2002 Jan; 290(1):349-58. PubMed ID: 11779176
[TBL] [Abstract][Full Text] [Related]
13. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
Seth D; Shaw K; Jazayeri J; Leedman PJ
Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641
[TBL] [Abstract][Full Text] [Related]
14. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.
Xu X; Kreye E; Kuo CB; Walker AM
Cancer Res; 2001 Aug; 61(16):6098-104. PubMed ID: 11507059
[TBL] [Abstract][Full Text] [Related]
15. Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands.
Carrión-Salip D; Panosa C; Menendez JA; Puig T; Oliveras G; Pandiella A; De Llorens R; Massaguer A
Int J Oncol; 2012 Sep; 41(3):1128-38. PubMed ID: 22684500
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells.
Mimeault M; Moore E; Moniaux N; Hénichart JP; Depreux P; Lin MF; Batra SK
Int J Cancer; 2006 Feb; 118(4):1022-31. PubMed ID: 16108016
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells.
Pu YS; Hsieh MW; Wang CW; Liu GY; Huang CY; Lin CC; Guan JY; Lin SR; Hour TC
Biochem Pharmacol; 2006 Mar; 71(6):751-60. PubMed ID: 16413505
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of prostate cancer cell growth by human secreted PDZ domain-containing protein 2, a potential autocrine prostate tumor suppressor.
Tam CW; Cheng AS; Ma RY; Yao KM; Shiu SY
Endocrinology; 2006 Nov; 147(11):5023-33. PubMed ID: 16873542
[TBL] [Abstract][Full Text] [Related]
19. EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer.
Huether A; Höpfner M; Baradari V; Schuppan D; Scherübl H
Biochem Pharmacol; 2005 Nov; 70(11):1568-78. PubMed ID: 16226226
[TBL] [Abstract][Full Text] [Related]
20. The depletion of cellular ATP by AG2034 mediates cell death or cytostasis in a hypoxanthine-dependent manner in human prostate cancer cells.
Obajimi O; Melera PW
Cancer Chemother Pharmacol; 2008 Jul; 62(2):215-26. PubMed ID: 17896107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
